PDF(1037 KB)
PDF(1037 KB)
PDF(1037 KB)
14例儿童肝母细胞瘤综合治疗的疗效观察
Treatment and outcome of 14 children with hepatoblastoma
目的：肝母细胞瘤是儿童时期最为常见的原发性肝脏恶性肿瘤。新辅助化疗﹢手术﹢术后化疗已成为肝母细胞瘤治疗的基本原则。该文旨在总结肝母细胞瘤综合治疗的疗效，进而探讨合理治疗的策略。方法：回顾性分析14例儿童肝母细胞瘤患者的临床资料，并追踪随访其治疗后的生存状况。结果：12例肝母细胞瘤患儿接受全程治疗，中位随访时间为18个月（1.5~74月）。9例无瘤存活，1例死亡，1例肿瘤转移，1例未发现肿瘤残留但术后甲胎蛋白持续不降。结论：手术及规范化疗能有效提高儿童肝母细胞瘤患者的生存率。［中国当代儿科杂志，2009，11（6）：456-459］
OBJECTIVE: To assess the outcome of childhood hepatoblastoma after a combination therapy of resection and chemotherapy. METHODS: The clinical data of 14 children with hepatoblastoma was retrospectively reviewed. Their long-term survival was followed-up. RESULTS: Twelve cases received surgery and planned chemotherapy. The follow-up duration averaged 18 months (range 1.5-74 months). Nine survived free of events, 1 died, 1 survived with multiple lung metastases, and 1 with increased alpha-fetoprotein (AFP) content but without residual tumor. CONCLUSIONS: Surgery assisted with chemotherapy can improve the outcome of hepatoblastoma.［Chin J Contemp Pediatr, 2009, 11 (6):456-459］
Hepatoblastoma / Chemotherapy / Surgery / Alphafetoprotein / Child
［1］高红，杨屹，漆衡，张可仞，王维林.巢式PCR法检测肝母细胞痛中p15和p16基因启动子异常甲基化［J］.中国当代儿科杂志，2005，7（5）：404-410.
［2］卢泳雪，何逾祥，黄志民，麦智广.儿童原发性肝癌的临床特点—附18例报告［J］.中国当代儿科杂志，2004，6（2）：152-153.
［3］Perilono G, Shafford EA. Liver tumors［J］. Eur J Cancer, 1999, 35(6): 953-958.
［4］Tiao GM, Bobey N, Allen S, Nieves N, Alonso M, Bucuvalas J, et al. The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation［J］. J Pediatr, 2005, 146(2): 204-211.
［5］Towu E, Kiely E, Pierro A, Spitz L. Outcome and complication after resection of hepatoblastoma［J］. J Pediatr Surg, 2004, 39(2): 199-202.
［6］Roebuck DJ, Aronson D, Clapuyt P, Czauderna P, de Ville de Goyet J, Gauthier F, et al. 2005 PRETEXT:a revised staging system for primary malignant liver tumors of childhood developed by the SIOPEL group［J］. Pediatr Radiol, 2007, 37(2):123-132.
［7］Czauderna P, Otte JB, Roebuck DJ, von Schweinitz D, Plaschkes J. Surgical treatment of hepatoblastoma in children［J］. Pediatr Radiol, 2006, 36(3):187-191.
［8］Perilongo G, Shafford E, Maibach R, Aronson D, Brugieres L, Brock P, et al. Risk-adapted treatment for childhood hepatoblastoma: final report of the second study of the International Society of Pediatric Oncology-SIOPEL 2［J］. Eur J Cancer, 2004, 40(3): 411-421.
［9］Ortega JA, Douglass EC, Feusner JH, Marleta R, John JQ, Milton JF, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusioin doxorubicin for treatment of pediatric hepatoblastoma: a report from the children′s cancer group and the pediatric oncology group［J］. J Clin Oncol, 2000, 18(14):2665-2675.
［10］Jiang XW, Li JH, Hu XL, Chen ZX. Combined treatment of hepatoblastoma with transcatheter arterial chemoembolization and surgery［J］. Pediatr Hematol Oncol, 2006, 23(1):1-9.
［11］Malogolowkin MH, Stanly P, Steele DA, Jorge AO. Feasibility and toxicity of chemoembolization for children with liver tumors［J］. J Clin Oncol, 2000, 18(6):1279-1284.
［12］唐咸明, 杨体泉, 董淳强, 罗意革, 陈嘉波, 谭志忠, 等. 肝动脉栓塞化疗及延期手术治疗小儿切除困难的肝母细胞瘤［J］. 中华小儿外科杂志, 2006, 27(1): 48-49.
［13］胡显良, 张利宾, 徐志诚. 肝母细胞瘤的介入治疗［J］. 中华小儿外科杂志, 2006, 27(11): 605-607.
［14］李穗生, 类成勇, 李作青, 刘钧澄, 莫家骢, 苏诚, 等. 术前化疗治疗肝母细胞瘤的应用价值［J］. 中华小儿外科杂志, 2008, 29(8): 460-462.
［15］De Ioris M, Brugieres L, Zimmermann A, Keeling J, Brock P, Maibach R, et al. Hepatoblastom with a low serum alpha-fetoprotein level at diagnosis: the SOIOPEL group experience［J］. Eur J Cancer, 2008, 44(4):545-550.
［16］D′Antiga L, Vallortigara F, Cillo U, Talenti E, Rugge M, Zancan L, et al. Features predicting unresectability in hepatoblastoma［J］.Cancer, 2007, 110(5):1050-1058.
